Trial Details
COMPLETEDBasic Information
| Clinical ID | c4079 |
|---|---|
| Identifier | NCT01086553 |
| Trial Title | 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn´s Disease |
| Interventions | DRUG: budesonide|DRUG: budesonide |
Participant Information
| Sponsor | Dr. Falk Pharma GmbH |
|---|---|
| City | Frankfurt |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2009-11 |
|---|---|
| Primary Completion Date | 2012-05 |
| Completion Date | 2012-12 |